| Literature DB >> 23781151 |
Anansa Bezerra de Aquino1, Luiz Henrique Agra Cavalcante-Silva, Carolina Barbosa Brito da Matta, Willians Antônio do Nascimento Epifânio, Pedro Gregório Vieira Aquino, Antônio Euzébio Goulart Santana, Magna Suzana Alexandre-Moreira, João Xavier de Araújo-Júnior.
Abstract
We investigated the antinociceptive and anti-inflammatory activities of the crude ethanolic extract (CEE), its fractions, and the flavonoid isorhamnetin from Aspidosperma tomentosum using models of nociception and inflammation in mice. In the writhing test, the CEE and its fractions (except for soluble phase, CHCl3 100% and EtAcO 100%) at 100 mg/kg p.o. induced antinociceptive activity. Isorhamnetin (100 μ mol/kg, p.o.) was also active. In the hot plate test, only the treatment with the fractions Hex : CHCl3 50%, CHCl3 100%, and CHCl3 : MeOH 5% (100 mg/kg, p.o.) increased the latency time, reversed by the opioid antagonist naloxone. Fractions that were active in the hot plate test did not show catalepsy condition. It was observed that CEE, all fractions, and isorhamnetin reduced the formalin effects in the neurogenic phase. In the inflammatory phase, only CEE, isorhamnetin, and CHCl3 100% and CHCl3 : MeOH 5% fractions were active. CEE and all fractions, except for CHCl3 : MeOH 10% fraction, isorhamnetin, and soluble fraction were able to produce an antioedematogenic activity in the ear capsaicin-induced edema test. In the thioglycolate-induced peritonitis, only EtAcO 100% fraction was not active. The results demonstrate that A. tomentosum has antinociceptive and anti-inflammatory activities in animal models.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23781151 PMCID: PMC3679822 DOI: 10.1155/2013/218627
Source DB: PubMed Journal: ScientificWorldJournal ISSN: 1537-744X
Figure 1Chemical structure of the flavonoid isorhamnetin (1).
Figure 2Antinociceptive effect of extract, fractions, and isorhamnetin (100 mg/kg, p.o.) on the acetic acid-induced writhings in mice. Each column represents the mean ± S.E.M. of 6 animals. Statistical differences between the treated and the control groups were evaluated by ANOVA and Dunnett hoc tests, and the asterisks denote the significance levels in comparison with control groups: *P < 0.05; **P < 0.01.
Effect of extract, fractions, and isorhamnetin in the hot plate test.
| Group | Pretreatment† | Posttreatment† | |||
|---|---|---|---|---|---|
| 0 min | 30 min | 60 min | 90 min | 120 min | |
| Vehicle | 4.2 ± 0.7 | 3.7 ± 0.7 | 3.7 ± 0.6 | 3.7 ± 0.7 | 4.7 ± 1.2 |
| Morphine | 12.8 ± 0.4** | 10.3 ± 0.8** | 9.7 ± 0.7** | 9.7 ± 0.9** | 12.8 ± 0.4** |
| CEE | 4.3 ± 0.5 | 4.8 ± 1.8 | 6.6 ± 1.2 | 5.9 ± 1.4 | 6.3 ± 0.9 |
| Isorhamnetin | 4.1 ± 0.5 | 4.7 ± 0.8 | 4.4 ± 0.7 | 3.6 ± 0.8 | 7.2 ± 1.7 |
| Soluble phase | 4.6 ± 0.7 | 5.0 ± 0.7 | 4.6 ± 0.8 | 3.1 ± 0.4 | 2.9 ± 0.5 |
| Hexane 100% | 3.2 ± 0.7 | 2.6 ± 0.4 | 3.0 ± 0.4 | 2.8 ± 0.5 | 3.1 ± 0.6 |
| Hex : CHCl3 50% | 4.6 ± 0.3 | 6.3 ± 0.9 | 7.4 ± 0.7* | 7.0 ± 1.5 | 7.3 ± 1.3 |
| CHCl3 100% | 3.0 ± 0.6 | 4.8 ± 0.6 | 7.8 ± 0.9* | 5.3 ± 0.2 | 6.3 ± 1.5 |
| CHCl3 : EtAcO 50% | 3.9 ± 0.7 | 4.3 ± 0.7 | 3.6 ± 0.4 | 3.3 ± 0.8 | 3.9 ± 0.8 |
| EtAcO 100% | 4.3 ± 1.0 | 2.9 ± 0.5 | 4.2 ± 0.6 | 5.4 ± 1.4 | 3.7 ± 0.6 |
| CHCl3 : MeOH 5% | 3.2 ± 0.8 | 8.5 ± 1.2** | 7.7 ± 1.6* | 6.7 ± 1.7 | 7.2 ± 1.1 |
| CHCl3 : MeOH 10% | 4.4 ± 0.8 | 5.2 ± 1.2 | 6.7 ± 0.7 | 6.9 ± 1.1 | 6.6 ± 1.2 |
†Data represented as mean ± S.E.M. Number of animals = 8. *P < 0.05; **P < 0.01. (One-way ANOVA and Dunnett test.)
Effect of fractions Hex : CHCl3 50%, CHCl3 100%, and CHCl3 : MeOH 5% in the hot plate test, in the presence of the drug nalaxone.
| Group | Pretreatment† | Posttreatment† | |||
|---|---|---|---|---|---|
| 0 min | 30 min | 60 min | 90 min | 120 min | |
| Vehicle | 4.2 ± 0.8 | 3.7 ± 0.7 | 3.7 ± 0.6 | 3.7 ± 0.7 | 4.7 ± 1.2 |
| Morphine | 5.9 ± 0.3 | 12.8 ± 0.4** | 10.3 ± 0.8** | 9.7 ± 0.7** | 9.7 ± 0.95** |
| Morphine + Nlx | 2.6 ± 0.5 | 3.3 ± 0.9 | 3.8 ± 0.7 | 2.6 ± 0.8 | 3.0 ± 0.4 |
| Hex : CHCl3 50% + Nlx | 2.6 ± 0.3 | 3.7 ± 0.5 | 1.2 ± 0.2 | 3.6 ± 0.8 | 2.4 ± 0.4 |
| CHCl3 100% + Nlx | 2.6 ± 0.4 | 4.2 ± 0.5 | 2.0 ± 0.4 | 3.2 ± 0.6 | 2.7 ± 0.3 |
| CHCl3 : MeOH 5% + Nlx | 3.2 ± 0.2 | 3.9 ± 0.8 | 3.0 ± 0.7 | 3.3 ± 0.5 | 5.0 ± 1.2 |
†Data represented as mean ± S.E.M. Number of animals = 8. *P < 0.05; **P < 0.01. (One-way ANOVA and Dunnett test.)
Effect of fractions Hex : CHCl3 50%, CHCl3 100%, and CHCl3 : MeOH 5% on catalepsy test.
| Group | 30 min | 60 min | 120 min | 180 min | 240 min |
|---|---|---|---|---|---|
| Vehicle | 5.0 ± 0.6 | 3.7 ± 1.1 | 6.5 ± 2.5 | 8.7 ± 2.9 | 5.7 ± 0.8 |
| Haloperidol | 103.2 ± 17.1*** | 174.8 ± 37.3*** | 201.6 ± 36.6*** | 230.5 ± 44.0*** | 261.8 ± 28.5*** |
| Hex : CHCl3 50% | 10.7 ± 2.0 | 22.1 ± 9.4 | 20.8 ± 7.4 | 19.5 ± 6.3 | 11.9 ± 2.9 |
| CHCl3 100% | 6.3 ± 1.9 | 4.3 ± 0.6 | 10.9 ± 2.5 | 13.0 ± 4.3 | 5.8 ± 0.7 |
| CHCl3 : MeOH 5% | 6.9 ± 2.9 | 7.9 ± 2.0 | 11.1 ± 5.1 | 10.9 ± 3.4 | 22.0 ± 7.9 |
†Data represented as mean ± S.E.M, number of animals = 6. ***P < 0.001 (One-way ANOVA and Dunnett test.)
Effects of extract, fractions (100 mg/kg, p.o.), isorhamnetin, and indomethacin (100 μmol/kg, p.o.) in nociception induced by formalin.
| Group |
| Linking (s) | % of inhibition | ||
|---|---|---|---|---|---|
| Phase 1 | Phase 2 | Phase 1 | Phase 2 | ||
| Mean ± S.E.M. | Mean ± S.E.M. | Mean ± S.E.M. | Mean ± S.E.M. | ||
| Vehicle | 6 | 82.8 ± 5.6 | 215.7 ± 24.0 | — | — |
| Indomethacin | 6 | 59.4 ± 8.1 | 94.6 ± 24.4 | 23.4* | 56.1** |
| CEE | 6 | 39.6 ± 2.4 | 75.8 ± 29.7 | 55.0** | 64.8** |
| Isorhamnetin | 6 | 59.4 ± 6.3 | 55.6 ± 32.7 | 35.7** | 74.2** |
| Soluble phase | 6 | 41.8 ± 3.4 | 139.6 ± 10.5 | 52.3** | 35.3 |
| Hexane 100% | 6 | 59.2 ± 4.4 | 195.0 ± 28.2 | 31.8** | 9.6 |
| Hex : CHCl3 50% | 6 | 62.7 ± 3.9 | 204.5 ± 42.4 | 24.2** | 5.2 |
| CHCl3 100% | 6 | 35.5 ± 7.0 | 51.2 ± 19.3 | 57.1** | 76.2** |
| CHCl3 : EtAcO 50% | 6 | 46.0 ± 5.2 | 131.2 ± 18.4 | 49.6** | 39.2 |
| EtAcO 100% | 6 | 56.0 ± 2.8 | 128.8 ± 9.7 | 32.4** | 40.3 |
| CHCl3 : MeOH 5% | 6 | 59.6 ± 3.7 | 84.6 ± 27.7 | 31.8** | 60.8** |
| CHCl3 : MeOH 10% | 6 | 42.2 ± 2.6 | 177.8 ± 16.3 | 52.0** | 17.6 |
Statistical differences between the treated and the control groups were evaluated by ANOVA and Dunnett test, and the asterisks denote the significance levels in comparison with control groups: *P < 0.05; **P < 0.01.
Figure 3Effects of extract, fractions, and isorhamnetin (100 mg/kg, p.o.) on the ear edema induced by capsaicin model. Each column represents the mean ± S.E.M. of 5 animals. The asterisks denote the significance levels in comparison with control groups, *P < 0.05.
Effects of extract, fractions (100 mg/kg, p.o.), and isorhamnetin (100 μmol/kg, p.o.) in the thioglycolate-induced peritonitis.
| Group |
| Cell number × 106/mL | % of inhibition |
|---|---|---|---|
| Mean ± S.E.M. | Mean ± S.E.M. | ||
| Vehicle | 6 | 1.5 ± 1.0 | — |
| CEE | 6 | 3.6 ± 0.4 | 57.6%** |
| Isorhamnetin | 6 | 4.6 ± 0.6 | 45.9%** |
| Soluble phase | 6 | 2.2 ± 0.3 | 74.1%** |
| Hexane 100% | 6 | 3.4 ± 0.4 | 60.0%** |
| Hex : CHCl3 50% | 6 | 1.7 ± 0.2 | 80.0%** |
| CHCl3 100% | 6 | 3.8 ± 0.5 | 55.3%** |
| CHCl3 : EtAcO 50% | 6 | 3.2 ± 0.6 | 62.3%** |
| EtAcO 100% | 6 | 8.6 ± 1.8 | 0.0% |
| CHCl3 : MeOH 5% | 6 | 2.4 ± 0.5 | 71.8%** |
| CHCl3 : MeOH 10% | 6 | 4.6 ± 0.5 | 45.9%** |
Statistical differences between the treated and the control groups were evaluated by ANOVA and Dunnett tests, and the asterisks denote the significance levels in comparison with control groups, **P < 0.01.